Table 2. Biochemical characteristics of patient 2.
| Characteristics | Reference | Days after admission |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 4 | 5a | 7b | 8b | 9 | 12b | 13 | ||
| TB (µmol/L) | 5–21 | 417.4 | 527.7 | 547.3 | 448.9 | 432.5 | 342.1 | 486.2 | 257.1 |
| IB (µmol/L) | <7 | 222.4 | 320 | 360 | 322.8 | 322.9 | 260.4 | 361.8 | 217.5 |
| DB (µmol/L) | – | 195 | 207.7 | 187.3 | 126.1 | 109.6 | 81.7 | 124.4 | 39.6 |
| ALB (g/L) | 40–55 | 21.5 | 31.7 | 32.8 | 32.1 | 35 | 29.6 | 33.4 | 26.7 |
| BAMR | – | 1.3 | 1.1 | 1.1 | 0.9 | 0.8 | 0.8 | 1.0 | 0.6 |
| ALT (U/L) | 9–50 | 57 | 58 | 59 | 58 | 63 | 71 | 88 | 63 |
| AST (U/L) | 15–40 | 222 | 249 | 233 | 171 | 160 | 171 | 191 | 169 |
| GGT (U/L) | 10–60 | 78 | 76 | 73 | 74 | 112 | |||
| ALP (U/L) | 45–125 | 513 | 460 | 327 | 282 | 334 | |||
| TBA (µmol/L) | <10 | 159.1 | 148.9 | 137.4 | 136.6 | 133.8 | |||
| WBC (×109/L) | 3.5–9.5 | 12.77 | 5.56 | 6.22 | 8.35 | 9.46 | 6.24 | 10.6 | |
| N% | 40–75 | 88.1 | 76.6 | 79.9 | 79.8 | 84.7 | 79 | 86.7 | |
| HGB (g/L) | 130–175 | 116 | 108 | 105 | 102 | 102 | 93 | 93 | |
| PLT (×109/L) | 125–350 | 237 | 161 | 176 | 176 | 188 | 156 | 173 | |
| Amon (µg/dL) | 19–54 | 41 | 107 | 116 | 81 | 74 | 108 | 75 | 89 |
a
The patient underwent DPMAS and plasma exchange.
b
The patient underwent plasma exchange.
Abbreviations: %N, proportion of neutrophils; ALB, albumin; ALP, alkaline phosphatase; Amon, blood ammonia; BAMR, Bilirubin-albumin molar ratio; DB, direct bilirubin; GGT, γ-glutamyl transferase; HGB, hemoglobin; IB, indirect bilirubin; PLT, platelets; TBA, total serum bile acid; WBC, white blood cell.